Voglibose 0.3 mg

Introduction

VOGLIGOLD 0.3 is an advanced oral antidiabetic tablet containing Voglibose 0.3 mg, specially formulated to manage postprandial hyperglycemia (PPHG) in people with type 2 diabetes mellitus (T2DM). Manufactured by Steris Healthcare Pvt Ltd, this tablet helps lower blood sugar spikes after meals and improves glycemic control when used alone or in combination with other antidiabetic medications.

What is Voglibose 0.3 mg?

Voglibose is an alpha-glucosidase inhibitor, a class of oral anti-diabetic agents that delays the digestion and absorption of carbohydrates in the intestine. It is particularly effective in managing blood sugar after meals, making it a crucial add-on therapy in type 2 diabetes patients who experience high post-meal glucose surges.

VOGLIGOLD 0.3 Tablet Uses

VOGLIGOLD 0.3 is used for:

• Postprandial blood sugar control in type 2 diabetes

• Adjunct therapy with sulfonylureas, metformin, insulin, or DPP-4 inhibitors

• Early-stage diabetes management in diet-controlled or newly diagnosed patients

• Effective in patients with impaired glucose tolerance (IGT) or prediabetes (if prescribed)

It is most beneficial when combined with dietary changes and exercise.

How Voglibose Works – Mechanism of Action

Voglibose inhibits the enzyme alpha-glucosidase in the small intestine, which is responsible for breaking down complex carbohydrates into simple sugars like glucose. By slowing this process:

• Glucose absorption is delayed

• Post-meal blood sugar spikes are reduced

• Insulin demand is minimized

Unlike sulfonylureas, Voglibose does not stimulate insulin secretion, so the risk of hypoglycemia is minimal when used alone.

Dosage and Administration

Typical Dose:

• 0.2 mg or 0.3 mg tablet three times a day, usually before meals

How to Take:

• Take immediately before the main meals

• Swallow whole with water

Your doctor may adjust the dose based on blood glucose levels and tolerability.

Benefits of VOGLIGOLD 0.3

• Targets postprandial glucose, a major contributor to HbA1c

• Non-insulinotropic – low risk of hypoglycemia when used alone

• Well-tolerated for long-term use

• Especially helpful in Indian diets rich in carbohydrates

• Safe option for elderly and obese patients

Side Effects of Voglibose 0.3 mg

Common Side Effects:

• Abdominal discomfort

• Flatulence (gas)

• Diarrhea or soft stools

• Bloating

Less Common Side Effects:

• Skin rash

• Elevated liver enzymes (rare, requires monitoring)

• Gastrointestinal intolerance in high doses

Side effects are often transient and improve with continued use or dose reduction.

Precautions and Warnings

• Avoid in patients with inflammatory bowel disease, intestinal obstruction, or chronic digestive issues

• Regular monitoring of liver function is advised in long-term use

• Not intended for use in type 1 diabetes

• Pregnancy & lactation: Use only if prescribed and monitored

Drug Interactions

• Effectiveness may be altered by digestive enzyme supplements or intestinal antibiotics

• Can be safely used with Metformin, Insulin, Sulfonylureas, DPP-4 inhibitors, and SGLT2 inhibitors

• Risk of hypoglycemia increases when used with insulin or sulfonylureas

Storage Instructions

• Store below 25°C in a cool, dry place

• Protect from light and moisture

• Keep away from children

Voglibose 0.3 mg Tablet Price in India

The price of VOGLIGOLD 0.3 is kept affordable by Steris Healthcare Pvt Ltd, ensuring accessibility to diabetic patients across India. Available at leading pharmacies and via Steris's trusted distribution channels.

Why Choose VOGLIGOLD 0.3 by Steris Healthcare?

• Formulated under WHO-GMP and ISO-certified facilities

• Quality-ensured with rigorous clinical and pharmacological checks

• Trusted by physicians across India

• Designed for maximum patient compliance and tolerability

FAQs about VOGLIGOLD 0.3 – Voglibose 0.3 mg Tablet

Q1. What is VOGLIGOLD 0.3 used for?

It is used to control post-meal blood sugar spikes in type 2 diabetic patients.

Q2. When should I take Voglibose 0.3 mg?

It should be taken just before meals, three times daily, or as directed by your doctor.

Q3. Does Voglibose cause hypoglycemia?

Not when taken alone. But the risk may increase if used with insulin or sulfonylureas.

Q4. Can Voglibose be used in combination with Metformin?

Yes, it is commonly prescribed alongside Metformin to improve overall glycemic control.

Q5. Is VOGLIGOLD 0.3 safe for long-term use?

Yes, when used under medical supervision, it is safe and well-tolerated for long durations.

Q6. Where can I buy VOGLIGOLD 0.3 in India?

You can purchase it at reputed pharmacies or through Steris Healthcare’s official network, a trusted pharma brand in India.

Q7. What if I miss a dose?

If you miss a dose, skip it if you're already done eating. Do not take it later on an empty stomach.

Conclusion

VOGLIGOLD 0.3 from Steris Healthcare Pvt Ltd offers targeted control for post-meal glucose spikes, helping you manage type 2 diabetes more effectively. With minimal side effects and high tolerability, it is an ideal companion in your diabetes care journey—especially in carbohydrate-heavy diets like those common in India.

Choose VOGLIGOLD 0.3 – For Smarter Post-Meal Blood Sugar Control.